Table 1. Baseline characteristics of the patients.
| HAIC N = 58 | Symptomatic treatment N = 44 | P-value | |
| Age (years) a | 61±12 | 63±17 | .407 |
| Sex (M/F) | 50/8 | 32/12 | .130 |
| HBV/non-HBV | 35/23 | 20/24 | .135 |
| Tumor size (cm) a | 11±3 | 11±3 | .277 |
| Tumor No (1/>1) | 25/33 | 18/26 | .824 |
| Albumin (g/dl) a | 3.3±0.6 | 3.1±0.5 | .177 |
| Bilirubin (mg/dl) a | 1.3±0.7 | 1.5±0.8 | .262 |
| AFP(>1000/<1000 ng/ml) | 31/27 | 24/20 | 1.000 |
| Main portal vein invasion (+/−) | 32/26 | 28/16 | .390 |
| Child class (A/B) | 30/28 | 20/24 | .530 |
| Okuda stage(1/2–3) | 6/52 | 5/39 | 1.000 |
| CLIP score(1–3/4–6) | 37/21 | 23/21 | .242 |
| BCLC stage (A–B/C–D) | 16/42 | 13/31 | 1.000 |
a
Data presented as mean +/− standard deviation.
AFP: alpha-fetoprotein, CLIP: Cancer of the Liver Italian Program, BCLC: Barcelona-Clinic Liver Cancer.